Best Practice & Research Clinical Gastroenterology
Volume 24, Issue 3 , Pages 271-280 , June 2010

The natural history of adenomas

  • Mauro Risio (Head of Department)

      Affiliations

    • Corresponding Author InformationTel.: +39 011 9933465; fax: +39 011 9933480.

References* 

  1. Boone CW, Kelloff GJ, Freedman SL. Intraepithelial and postinvasive neoplasia as a stochastic continuum of clonal evolution. J Cell Biochem. 1993;17G:14–25
  2. Chen L-C, Hao C-Y, Chiu YSY, Wong P, Melnick JS, Brotman M, et al. Alteration of gene expression in normal-appearing colon mucosa of APCmin mice and human cancer patients. Cancer Res. 2004;64:3694–3700
  3. Akedo I, Ishikawa H, Ioka T, Kaji I, Narahara H, Ishiguro S, et al. Evaluation of epithelial cell proliferation rate in normal-appearing colonic mucosa as a high-risk marker for colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2001;10:925–930
  4. Risio M, Lipkin M, Candelaresi GL, Bertone A, Coverlizza S, Rossini FP. Correlations between rectal mucosa cell proliferation and the clinical and pathological features of nonfamilial neoplasia of the large intestine. Cancer Res. 1991;51:1917–1921
  5. Risio M, Lipkin M, Newmark H, Yang K, Rossini FP, Steele VE, et al. Apoptosis, cell replication, and western-style diet-induced tumorigenesis in colon. Cancer Res. 1996;56:4910–4916
  6. Wong WM, Mandir N, Goodlad RA, Wong BC, Garcia SB, Lam SK, et al. Histogenesis of colorectal adenomas and hyperplastic polyps: the role of cell proliferation and crypt fission. Gut. 2002;50:212–217
  7. Figueiredo P, Donato M, Urbano M, Goulao H, Sofia C, Leitao M, et al. Aberrant crypt foci: endoscopic assessment and cell kinetics characterization. Dis Colon Rectum. 2009;24:441–450
  8. Schoen RE, Mutch M, Rall C, Dry SM, Seligson D, Umar A, et al. The natural history of aberrant crypt foci. Gastrointest Endosc. 2008;67:1097–1102
  9. Eide TJ. Risk of colorectal cancer in adenoma-bearing individuals within a defined population. Int J Cancer. 1986;15:173–176
  10. Hoff G, Foerster A, Vatn MH, Sanar J, Larson S. Epidemiology of polyps in the rectum and colon: recovery and evaluation of unresected polyps two years after detection. Scand J Gastroenterol. 1986;21:853–862
  11. Muto T, Bussey HJR, Morson BC. The evolution of cancer of the rectum. Cancer. 1975;36:2251–2270
  12. In:  Day DW,  Jass JR,  Price AB,  Shepherd NA,  Sloan JM,  Talbot IC, et al. editor. Morson and Dawson’s gastrointestinal pathology. 4th ed.. Malden: Blackwell Publishing; 2003;p. 551–609
  13. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polipectomy. N Engl J Med. 1993;329:1977–1981
  14. Rubio CA. Atypical mitoses in colorectal adenomas. Pathol Res Pract. 1991;187:508–513
  15. Winawer SJ, Zauber AG, Fletcher RH, Stillman JS, O'Brien MJ, Levin B, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on colorectal cancer and the American Cancer Society. Gastroenterology. 2006;130:1872–1885
  16. Lieberman DA, Weiss DG, Harford WV, Ahnen DJ, Provenzale D, Sontag SJ, et al. Five-year surveillance after screening colonoscopy. Gastroenterology. 2007;133:1077–1085
  17. Risio M, Malacarne D, Giaretti W. KRAS transitions and villous growth in colorectal adenomas. Cell Oncol. 2005;27:363–366
  18. Venesio T, Balsamo A, Scordamaglia A, Bertolaso M, Arrigoni A, Sprujevnik T, et al. Germline APC mutation on the B-catenin binding site is associated with a decreased apoptotic level in colorectal adenoma. Mod Pathol. 2003;16:57–65
  19. Castedo M, Perfettini J-L, Roumier T, Valent A, Raslova H, Yakushijin K, et al. Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy. Oncogene. 2004;23:4362–4370
  20. Thiis-Evensen E, Hoff GS, Sauar J, Majak BM, Vatn MH. The effect of attending a flexible sigmoidoscopic screening program on the prevalence of colorectal adenomas at 13-year follow-up. Am J Gastroenterol. 2001;96:1901–1907
  21. Giardiello FM, Offerhaus JA, Tersmette AC, Hylind LM, Krush AJ, Brensinger JD, et al. Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: evaluation of predictive factors. Gut. 1996;38:578–581
  22. Keller JJ, Ogfferhaus GJ, Hylind LM, Giardiello FM. Rectal epithelial apoptosis does not predict response to sulindac treatment or polyp development in presymptomatic familial adenomatous polyposis patients. Cancer Epidemiol Biomarkers Prev. 2002;11:670–671
  23. Koornstra JJ, Rijcken FE, Oldenhuis CN, Zwart N, van der Sluis T, Hollema H, et al. Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients. Cancer Epidemiol Biomarkers Prev. 2005;14:1608–1612
  24. Bersentes K, Fennerty MB, Sampliner RE, Garewal HS. Lack of spontaneous regression of tubular adenomas in two years of follow-up. Am J Gastroenterol. 1997;92:1117–1120
  25. Loeve F, Boer R, Zauber AG, Van Ballegooijen M, Van Oortmerssen GJ, Winawer SJ, et al. National polyp study data: evidence for regression of adenomas. Int J Cancer. 2004;111:633–639
  26. Soetikno RM, Kaltenbach T, Rouse RV, Park W, Maeshwari A, Sato T, et al. Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA. 2008;299:1027–1035
  27. Hiraoka S, Kato J, Tatsukawa M, Harada K, Fujita H, Morikawa T, et al. Laterally spreading type of colorectal adenoma exhibits a unique methylation phenotype and K-ras mutations. Gastroenterology. 2006;131:379–389
  28. Soetikno R, Friedland S, Kaltenbach T, Chayama K, Tanaka S. Nonpolypoid (flat and depressed) colorectal neoplasms. Gastroenterology. 2006;130:566–576
  29. Risio M, Sarotto I, Rossini FP, Newmark H, Yang K, Lipkin M. Programmed cell death, proliferating cell nuclear antigen and p53 expression in mouse colon mucosa during diet/induced tumorigenesis. Anal Cell Pathol. 2000;2:87–94
  30. Tateyama H, Li W, Takahashi E, Miura Y, Sugiura H, Eimoto T. Apoptosis index and apoptosis-related antigen expression in serrated adenoma of the colorectum. The saw-toothed structure may be related to inhibition of apoptosis. Am J Surg Pathol. 2002;26:249–256
  31. Jass JR, Whitehall VL, Young J, Leggett BA. Emerging concepts in colorectal neoplasia. Gastroenterology. 2002;123:862–876
  32. Torlakovic EE, Gomez JD, Driman DK, Parfitt JR, Wang C, Benerjee T, et al. Sessile serrated adenoma (SSA) vs traditional serrated adenoma (TSA). Am J Surg Pathol. 2008;32:21–29
  33. Martinez ME, McPherson LS, Levin B, Glober GA. A case-control study of dietary intake and other lifestyle risk factors for hyperplastic polyps. Gastroenterology. 1997;113:423–427
  34. Risio M, Arrigoni A, Pennazio M, Agostinucci A, Spandre M, Rossini FP. Mucosal cell proliferation in patients with hyperplastic colorectal polyps. Scand J Gastroenterol. 1995;30:344–348
  35. Snover DC, Jass JR, Fenoglio-Preiser C, Batts KP. Serrated polyps of the large intestine. A morphological and molecular review of an evolving concept. Am J Clin Pathol. 2005;124:380–389
  36. Farris AB, Misdraji JM, Srivastava A, Muzikansky A, Deshpande V, Lauwers GY, et al. Sessile serrated adenoma. Challenging discrimination from other serrated colonic polyps. Am J Surg Pathol. 2008;32:30–35
  37. Higuchi T, Sugihara K, Jass JR. Demographic and pathological characteristics of serrated polyps of colorectum. Histopathology. 2005;47:32–40
  38. Makinen MJ. Colorectal serrated adenocarcinoma. Histopathology. 2007;50:131–150
  39. Jass JR, Baker K, Zlobec I, Higuchi T, Barker M, Buchaman D, et al. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a “fusion” pathway to colorectal cancer. Histopathology. 2006;49:121–131
  40. Rozen P, Samuel Z, Brazowski E. A prospective study of the clinical, genetic, screening, and pathologic features of a family with hereditary mixed polyposis syndrome. Am J Gastroenterol. 2003;98:2317–2320
  41. Matsumoto T, Iida M, Kobori Y, Mizuno M, Nakamura S, Hizawa K, et al. Serrated adenomas in familial adenomatous polyposis: relation to germline APC gene mutation. Gut. 2002;50:402–404
  42. Venesio T, Molatore S, Cattaneo F, Arrigoni A, Risio M, Ranzani GN. High frequency of MYH gene mutations in a subset of patients with familial adenomatous polyposis. Gastroenterology. 2004;126:1681–1686
  43. Kawasaki T, Ohnishi M, Nosho K, Suemoto Y, Kirkner GJ, Meyerhardt JA, et al. CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci. Mod Pathol. 2008;21:245–255
  44. Minoo P, Jass JR. Senescence and serration: a new twist to an old tale. J Pathol. 2006;210:137–140
  45. Carr NJ, Mahajan H, Tan KL, Hawkins NJ, Ward RL. Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol. 2009;62:516–518
  46. Kambara T, Simms LA, Whitehall VLJ, Spring KJ, Wynter CV, Walsh MD, et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut. 2004;53:1137–1144
  47. Makinen MJ, George SM, Jernvall P, Makela J, Vihko P, Karttunen TJ. Colorectal carcinoma associated with serrated adenoma. Prevalence, histological features, and prognosis. J Pathol. 2001;193:286–294
  48. Longacre TA, Fenoglio-Preiser CM. Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol. 1990;14:524–537
  49. Goldstein NS, Bhanot P, Odish E, Hunter S. Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol. 2003;119:778–796
  50. Hawkins NJ, Ward RL. Sporadic colorectal cancer with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst. 2001;93:1307–1313
  51. Rubio CA, Stemme S, Jaramillo E, Lindblom A. Hyperplastic polyposis coli syndrome and colorectal carcinoma. Endoscopy. 2006;38:266–270
  52. Fenoglio CM, Kaye GI, Lane N. Distribution of human colonic lymphatics in normal, hyperplastic, and adenomatous tissue. Its relationship to metastasis from small carcinomas in peduncolated adenomas, with two case reports. Gastroenterology. 1973;64:51–66
  53. Coverlizza S, Risio M, Ferrari A, Fenoglio-Preiser CM, Rossini FP. Colorectal adenomas containing invasive carcinoma. Pathologic assessment of lymph node metastatic potential. Cancer. 1989;64:1937–1947
  54. Hassan C, Zullo A, Risio M, Rossini FP, Morini S. Histologic risk factors and clinical outcome in colorectal malignant polyp: a pooled-data analysis. Dis Colon Rectum. 2005;48:1588–1596
  55. Prall F. Tumour budding in colorectal carcinoma. Histopathology. 2007;50:151–162
  56. Kazama S, Watanabe T, Ajioka Y, Kanazawa T, Nagawa H. Tumor budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2. Br J Cancer. 2006;94:293–298
  57. Ogawa T, Yoshida T, Tsuruta T, Tokuyama W, Adachi S, Kikuchi M, et al. Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinoma and non-polypoid compared with polypoid growths. Scand J Gastroenterol. 2009;44:605–614
  58. Gunderson LL, Jessup MJ, Sargent DJ, Greene FL, Stewart AK. Revised TN categorization for rectal and colon cancers based on national survival outcome data. J Clin Oncol. 2010;28:264–271
  59. Risio M, Casorzo L, Chiecchio L, De Rosa G, Rossini FP. Deletions of 17p are associated with transition from early to advanced colorectal cancer. Cancer Genet Cytogenet. 2003;147:44–49

PII: S1521-6918(10)00059-4

doi: 10.1016/j.bpg.2010.04.005

Best Practice & Research Clinical Gastroenterology
Volume 24, Issue 3 , Pages 271-280 , June 2010

Article Tools